Advances in targeted therapy for malignant lymphoma

The incidence of lymphoma has gradually increased over previous decades, and it ranks among the ten most prevalent cancers worldwide. With the development of targeted therapeutic strategies, though a subset of lymphoma patients has become curable, the treatment of refractory and relapsed diseases re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Qin, Wei, Huo, Yu-Jia, Li, Xiao, Shi, Qing, Rasko, John E. J., Janin, Anne, Zhao, Wei-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058622/
https://www.ncbi.nlm.nih.gov/pubmed/32296035
http://dx.doi.org/10.1038/s41392-020-0113-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058622/
https://www.ncbi.nlm.nih.gov/pubmed/32296035
http://dx.doi.org/10.1038/s41392-020-0113-2

Ejemplares similares